Editorial history and review method
Revision 6 · Approved for publication · Codex (publication approval explicitly authorized by site owner; category migration)
Prepared and checked with AI. Publication approval does not imply independent expert review. Request a correction.
Revision 3, applying the high-risk audit corrections (_report-focus-a.md). The katz-2021 DOI had already been corrected by the parent (10.1016/j.jand.2020.12.021) and was left untouched. Changes: (1) the executive-function finding is relabelled from "Mixed evidence" to "Little/no effect" so it matches the entry's own headline and summary, and its certaintyRationale now sets out why. (2) The Katz review's actual numbers were added - 33 studies, 3,636 participants, roughly half neutral or unclear and half showing domain effects, euhydration studies slightly more likely to show improvement, healthy and diseased adults over 18 - to the summary, population and limitations, together with the explicit statement that no cited study tested extra water in already-hydrated adults. (3) The adverse signal the review contains is now disclosed in the extra-water-health-outcomes limitations: daytime mean arterial pressure rose from 89.0 to 91.4 mm Hg (P = .005) over two weeks of an extra 30 mL/kg/day in healthy adults, and a crossover in overactive bladder found that reducing fluid intake by 25% reduced daytime frequency, urgency and nocturia. (4) Precaution 1 no longer says only "excessive water intake can be harmful" - it names hyponatraemia and the blood-pressure trial.
A second reviewer must re-check: (a) the exact references behind the two adverse findings are Jormeus 2010 and Hashim 2008 as reported in the Hakam 2024 full text; neither is a separate source in sources.json, so if the catalogue requires every outcome number to be traceable to a stored source record, those two trials need adding; (b) the national-academies-2005-water facts remain unverified from this seat and still carry the Strong certainty rating on physiological-hydration; (c) whether "Little/no effect" is preferred over "Mixed evidence" with the mixture named - the audit report allows either and this revision took the first option; (d) that no sentence implies extra water improves cognition in already-hydrated adults. EFSA water verification: the EFSA 2010 opinion was retrieved in full in this pass and both of its stored facts are confirmed verbatim, so its `accessLevel: full_text` claim - previously asserted without anyone having read it - is now accurate. The opinion is cited from this outcome as a second authoritative reference alongside the National Academies, and the summary now states what each body actually defines: an Adequate Intake for total water covering drinking water, other beverages and food moisture, under moderate environmental temperature and moderate physical activity (PAL 1.6), and not an individual requirement. A reviewer should note the deliberate omission: there is no sentence in the opinion saying the Adequate Intake is not a target for individuals, so the entry makes the narrower statements the document does make. The separate 2011 EFSA health-claim opinion whose condition of use is 'at least 2.0 L of water per day' is a different instrument and is not merged with the Adequate Intake here - it is recorded in SOURCE-VERIFICATION.md instead.
October 3 training follow-up: Added a conditional timing adaptation for nocturia, consistent with the existing bladder evidence; no universal bedtime cutoff. Independent editorial approval remains pending. Publication release 2026-10-04: site owner authorized a bounded AI audit and release of this exact revision. See docs/release-audit-2026-10-04.md for source-check findings and limits. No independent health-professional or peer review is claimed.
Category migration 2026-10-04: removed the separate goals field; categories: Nutrition, Energy → Nutrition, Energy, Focus. Research assessments, sources, guidance, precautions, and evidence review dates are unchanged. This revision awaits publication approval; no new evidence review is claimed.
Publication approval 2026-10-04: site owner explicitly accepted all current category-migration revisions for deployment and requested that remaining limitations be retained in docs/content-review-backlog.md. Approval applies to this exact content revision. No new evidence review, independent expert review, or clinical validation is claimed; existing precautions and disclosures remain in effect.